- Home
- KFY vs VKTX Comparison
KFY vs VKTX Comparison
Compare KFY & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFY
- VKTX
- Stock Information
- Founded
- KFY 1969
- VKTX 2012
- Country
- KFY United States
- VKTX United States
- Employees
- KFY N/A
- VKTX N/A
- Industry
- KFY Diversified Commercial Services
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- KFY Consumer Discretionary
- VKTX Health Care
- Exchange
- KFY Nasdaq
- VKTX Nasdaq
- Market Cap
- KFY 3.6B
- VKTX 3.0B
- IPO Year
- KFY 1999
- VKTX 2015
- Fundamental
- Price
- KFY $70.62
- VKTX $31.60
- Analyst Decision
- KFY Buy
- VKTX Strong Buy
- Analyst Count
- KFY 2
- VKTX 12
- Target Price
- KFY $80.00
- VKTX $86.42
- AVG Volume (30 Days)
- KFY 470.9K
- VKTX 5.3M
- Earning Date
- KFY 09-09-2025
- VKTX 10-22-2025
- Dividend Yield
- KFY 2.71%
- VKTX N/A
- EPS Growth
- KFY 33.45
- VKTX N/A
- EPS
- KFY 4.69
- VKTX N/A
- Revenue
- KFY $2,763,755,000.00
- VKTX N/A
- Revenue This Year
- KFY $4.39
- VKTX N/A
- Revenue Next Year
- KFY $4.42
- VKTX N/A
- P/E Ratio
- KFY $15.11
- VKTX N/A
- Revenue Growth
- KFY 0.93
- VKTX N/A
- 52 Week Low
- KFY $59.23
- VKTX $18.92
- 52 Week High
- KFY $80.64
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- KFY 44.36
- VKTX 62.28
- Support Level
- KFY $68.65
- VKTX $25.04
- Resistance Level
- KFY $73.25
- VKTX $26.96
- Average True Range (ATR)
- KFY 1.29
- VKTX 1.67
- MACD
- KFY -0.10
- VKTX 1.00
- Stochastic Oscillator
- KFY 33.81
- VKTX 88.05
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.